CE Activities

Challenging Cases in Oncology: Managing Opioid-Induced Constipation in Cancer Patients
Challenging Cases in Oncology: Managing Opioid-Induced Constipation in Cancer Patients
CME, CPE, CNE, AANP CE
Jeffrey A. Gudin, MD; Yvonne D’Arcy, MS, ARNP-C, CNS, FAANP; Jeffrey Fudin, RPh, PharmD, DAIPM, FCCP, FASHP
Release Date: April 30, 2018
Expiration Date: April 30, 2019
This activity will consist of a blend of interactive discussions and slide-based presentations which focus on a case study that will exemplify the need to assess for and treat opioid-induced constipation (OIC) in patients with chronic cancer-related pain. The interactive discussion among the panel will provide a comprehensive look at the importance of patient-centered care which focuses on early assessment, ongoing patient communication, and active management of OIC. Oncology practitioners will be introduced to new advances in the treatment of OIC resulting from chronic cancer-related pain.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from AstraZeneca
Begin, Earn CreditView Only, No Credit
 
Empowering Community Oncologists in the New Era of Cancer Management: ADAPTATION OF THE IMMUNO-ONCOLOGY REGIONAL MEETING SERIES
Empowering Community Oncologists in the New Era of Cancer Management: ADAPTATION OF THE IMMUNO-ONCOLOGY REGIONAL MEETING SERIES
CME, CPE, CNE
Bradley C. Carthon, MD, PhD; Jason J. Luke, MD, FACP; Jeffrey S. Weber, MD, PhD
Release Date: May 07, 2015
Expiration Date: May 07, 2016
Drs. Carthon, Luke, and Weber discuss the growth of new science in immuno-oncology, guideline updates, and advances to better understand and apply these new options in community practice.

Provided by MediCom Worldwide, Inc.

This activity is supported by educational grants from AstraZeneca, Bristol-Myers Squibb, Genentech, and Prometheus Therapeutics & Diagnostics

View Only, CE ExpiredView Only, No Credit
 
Individualizing Therapeutic Options and Achieving Goals in Chronic Lymphocytic Leukemia (CLL)
Individualizing Therapeutic Options and Achieving Goals in Chronic Lymphocytic Leukemia (CLL)
CME
Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD; Peter Hillmen, MD, FRCP, FRCPath, PhD; Thomas J. Kipps, MD
Release Date: March 17, 2015
Expiration Date: March 17, 2016
Drs. Burger, Brown, Hillmen, and Kipps discuss critical information, expert guidelines, and recommendations concerning evolving treatment paradigms in chronic lymphocytic leukemia (CLL) as well as address current clinical controversies. This accredited activity presents the most up-to-date data, recommendations, and practice standards in order to help participants gain additional knowledge and understanding required to assess all possible therapeutic strategies for patients with CLL.

Provided by MediCom Worldwide, Inc. and The University of Texas MD Anderson Cancer Center

This activity has been supported by educational grants from Pharmacyclics, Inc. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and from Teva Pharmaceuticals.

View Only, CE ExpiredView Only, No Credit